HHS Secretary Robert F. Kennedy Jr. announced eight new members that will sit on the expert panel that advises the Centers for Disease Control and Prevention, or CDC, on vaccine policy, and “said they would review the current vaccine schedule, as well as evaluate new shots.” These appointments follow Kennedy dismissing every member of the committee just days ago. Publicly traded companies in the space include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Johnson & Johnson reports results from Phase 3b APEX study on TREMFYA
- Johnson & Johnson Elects Daniel Pinto to Board
- Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel
- Deutsche Bank Sounds Alarm on Intuitive Surgical Stock (ISRG) with a Rare ‘Sell’ Rating
- RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members